Pharma & Healthcare
Global AAV Gene Therapy Drugs Market Research Report 2026
- Feb 03, 26
- ID: 693948
- Pages: 109
- Figures: 106
- Views: 3
This report delivers a comprehensive overview of the global AAV Gene Therapy Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AAV Gene Therapy Drugs. The AAV Gene Therapy Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global AAV Gene Therapy Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist AAV Gene Therapy Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Avexis/Novartis (Zolgensma)
Sarepta Therapeutics (Elevidys)
Spark/Roche (Luxturna)
PTC Therapeutics (Upstaza)
BioMarin (Roctavian)
CSL/uniQure (Hemgenix&Glybera)
Pfizer
Beijing Innovikang (Pipeline)
Suzhou NoJieBeig (Pipeline)
Belief BioMed (Pipeline)
Segment by Type
scAAV9 Vector
AVV2 Vector
AVV5 Vector
AAVrh74 Vector
Segment by Application
Spinal Muscular Atrophy (SMA)
Ophthalmic Diseases
Hemophilia
Duchenne Muscular Dystrophy (DMD)
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AAV Gene Therapy Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global AAV Gene Therapy Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist AAV Gene Therapy Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Avexis/Novartis (Zolgensma)
Sarepta Therapeutics (Elevidys)
Spark/Roche (Luxturna)
PTC Therapeutics (Upstaza)
BioMarin (Roctavian)
CSL/uniQure (Hemgenix&Glybera)
Pfizer
Beijing Innovikang (Pipeline)
Suzhou NoJieBeig (Pipeline)
Belief BioMed (Pipeline)
Segment by Type
scAAV9 Vector
AVV2 Vector
AVV5 Vector
AAVrh74 Vector
Segment by Application
Spinal Muscular Atrophy (SMA)
Ophthalmic Diseases
Hemophilia
Duchenne Muscular Dystrophy (DMD)
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AAV Gene Therapy Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AAV Gene Therapy Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 scAAV9 Vector
1.2.3 AVV2 Vector
1.2.4 AVV5 Vector
1.2.5 AAVrh74 Vector
1.3 Market by Application
1.3.1 Global AAV Gene Therapy Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Spinal Muscular Atrophy (SMA)
1.3.3 Ophthalmic Diseases
1.3.4 Hemophilia
1.3.5 Duchenne Muscular Dystrophy (DMD)
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AAV Gene Therapy Drugs Market Perspective (2021–2032)
2.2 Global AAV Gene Therapy Drugs Growth Trends by Region
2.2.1 Global AAV Gene Therapy Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 AAV Gene Therapy Drugs Historic Market Size by Region (2021–2026)
2.2.3 AAV Gene Therapy Drugs Forecasted Market Size by Region (2027–2032)
2.3 AAV Gene Therapy Drugs Market Dynamics
2.3.1 AAV Gene Therapy Drugs Industry Trends
2.3.2 AAV Gene Therapy Drugs Market Drivers
2.3.3 AAV Gene Therapy Drugs Market Challenges
2.3.4 AAV Gene Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AAV Gene Therapy Drugs Players by Revenue
3.1.1 Global Top AAV Gene Therapy Drugs Players by Revenue (2021–2026)
3.1.2 Global AAV Gene Therapy Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top AAV Gene Therapy Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by AAV Gene Therapy Drugs Revenue
3.4 Global AAV Gene Therapy Drugs Market Concentration Ratio
3.4.1 Global AAV Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AAV Gene Therapy Drugs Revenue in 2025
3.5 Global Key Players of AAV Gene Therapy Drugs Head Offices and Areas Served
3.6 Global Key Players of AAV Gene Therapy Drugs, Products and Applications
3.7 Global Key Players of AAV Gene Therapy Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 AAV Gene Therapy Drugs Breakdown Data by Type
4.1 Global AAV Gene Therapy Drugs Historic Market Size by Type (2021–2026)
4.2 Global AAV Gene Therapy Drugs Forecasted Market Size by Type (2027–2032)
5 AAV Gene Therapy Drugs Breakdown Data by Application
5.1 Global AAV Gene Therapy Drugs Historic Market Size by Application (2021–2026)
5.2 Global AAV Gene Therapy Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America AAV Gene Therapy Drugs Market Size (2021–2032)
6.2 North America AAV Gene Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America AAV Gene Therapy Drugs Market Size by Country (2021–2026)
6.4 North America AAV Gene Therapy Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AAV Gene Therapy Drugs Market Size (2021–2032)
7.2 Europe AAV Gene Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe AAV Gene Therapy Drugs Market Size by Country (2021–2026)
7.4 Europe AAV Gene Therapy Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AAV Gene Therapy Drugs Market Size (2021–2032)
8.2 Asia-Pacific AAV Gene Therapy Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific AAV Gene Therapy Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific AAV Gene Therapy Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AAV Gene Therapy Drugs Market Size (2021–2032)
9.2 Latin America AAV Gene Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America AAV Gene Therapy Drugs Market Size by Country (2021–2026)
9.4 Latin America AAV Gene Therapy Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AAV Gene Therapy Drugs Market Size (2021–2032)
10.2 Middle East & Africa AAV Gene Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa AAV Gene Therapy Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa AAV Gene Therapy Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Avexis/Novartis (Zolgensma)
11.1.1 Avexis/Novartis (Zolgensma) Company Details
11.1.2 Avexis/Novartis (Zolgensma) Business Overview
11.1.3 Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Introduction
11.1.4 Avexis/Novartis (Zolgensma) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.1.5 Avexis/Novartis (Zolgensma) Recent Development
11.2 Sarepta Therapeutics (Elevidys)
11.2.1 Sarepta Therapeutics (Elevidys) Company Details
11.2.2 Sarepta Therapeutics (Elevidys) Business Overview
11.2.3 Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Introduction
11.2.4 Sarepta Therapeutics (Elevidys) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.2.5 Sarepta Therapeutics (Elevidys) Recent Development
11.3 Spark/Roche (Luxturna)
11.3.1 Spark/Roche (Luxturna) Company Details
11.3.2 Spark/Roche (Luxturna) Business Overview
11.3.3 Spark/Roche (Luxturna) AAV Gene Therapy Drugs Introduction
11.3.4 Spark/Roche (Luxturna) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.3.5 Spark/Roche (Luxturna) Recent Development
11.4 PTC Therapeutics (Upstaza)
11.4.1 PTC Therapeutics (Upstaza) Company Details
11.4.2 PTC Therapeutics (Upstaza) Business Overview
11.4.3 PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Introduction
11.4.4 PTC Therapeutics (Upstaza) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.4.5 PTC Therapeutics (Upstaza) Recent Development
11.5 BioMarin (Roctavian)
11.5.1 BioMarin (Roctavian) Company Details
11.5.2 BioMarin (Roctavian) Business Overview
11.5.3 BioMarin (Roctavian) AAV Gene Therapy Drugs Introduction
11.5.4 BioMarin (Roctavian) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.5.5 BioMarin (Roctavian) Recent Development
11.6 CSL/uniQure (Hemgenix&Glybera)
11.6.1 CSL/uniQure (Hemgenix&Glybera) Company Details
11.6.2 CSL/uniQure (Hemgenix&Glybera) Business Overview
11.6.3 CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Introduction
11.6.4 CSL/uniQure (Hemgenix&Glybera) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.6.5 CSL/uniQure (Hemgenix&Glybera) Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer AAV Gene Therapy Drugs Introduction
11.7.4 Pfizer Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.7.5 Pfizer Recent Development
11.8 Beijing Innovikang (Pipeline)
11.8.1 Beijing Innovikang (Pipeline) Company Details
11.8.2 Beijing Innovikang (Pipeline) Business Overview
11.8.3 Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Introduction
11.8.4 Beijing Innovikang (Pipeline) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.8.5 Beijing Innovikang (Pipeline) Recent Development
11.9 Suzhou NoJieBeig (Pipeline)
11.9.1 Suzhou NoJieBeig (Pipeline) Company Details
11.9.2 Suzhou NoJieBeig (Pipeline) Business Overview
11.9.3 Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Introduction
11.9.4 Suzhou NoJieBeig (Pipeline) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.9.5 Suzhou NoJieBeig (Pipeline) Recent Development
11.10 Belief BioMed (Pipeline)
11.10.1 Belief BioMed (Pipeline) Company Details
11.10.2 Belief BioMed (Pipeline) Business Overview
11.10.3 Belief BioMed (Pipeline) AAV Gene Therapy Drugs Introduction
11.10.4 Belief BioMed (Pipeline) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.10.5 Belief BioMed (Pipeline) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AAV Gene Therapy Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 scAAV9 Vector
1.2.3 AVV2 Vector
1.2.4 AVV5 Vector
1.2.5 AAVrh74 Vector
1.3 Market by Application
1.3.1 Global AAV Gene Therapy Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Spinal Muscular Atrophy (SMA)
1.3.3 Ophthalmic Diseases
1.3.4 Hemophilia
1.3.5 Duchenne Muscular Dystrophy (DMD)
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AAV Gene Therapy Drugs Market Perspective (2021–2032)
2.2 Global AAV Gene Therapy Drugs Growth Trends by Region
2.2.1 Global AAV Gene Therapy Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 AAV Gene Therapy Drugs Historic Market Size by Region (2021–2026)
2.2.3 AAV Gene Therapy Drugs Forecasted Market Size by Region (2027–2032)
2.3 AAV Gene Therapy Drugs Market Dynamics
2.3.1 AAV Gene Therapy Drugs Industry Trends
2.3.2 AAV Gene Therapy Drugs Market Drivers
2.3.3 AAV Gene Therapy Drugs Market Challenges
2.3.4 AAV Gene Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AAV Gene Therapy Drugs Players by Revenue
3.1.1 Global Top AAV Gene Therapy Drugs Players by Revenue (2021–2026)
3.1.2 Global AAV Gene Therapy Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top AAV Gene Therapy Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by AAV Gene Therapy Drugs Revenue
3.4 Global AAV Gene Therapy Drugs Market Concentration Ratio
3.4.1 Global AAV Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AAV Gene Therapy Drugs Revenue in 2025
3.5 Global Key Players of AAV Gene Therapy Drugs Head Offices and Areas Served
3.6 Global Key Players of AAV Gene Therapy Drugs, Products and Applications
3.7 Global Key Players of AAV Gene Therapy Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 AAV Gene Therapy Drugs Breakdown Data by Type
4.1 Global AAV Gene Therapy Drugs Historic Market Size by Type (2021–2026)
4.2 Global AAV Gene Therapy Drugs Forecasted Market Size by Type (2027–2032)
5 AAV Gene Therapy Drugs Breakdown Data by Application
5.1 Global AAV Gene Therapy Drugs Historic Market Size by Application (2021–2026)
5.2 Global AAV Gene Therapy Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America AAV Gene Therapy Drugs Market Size (2021–2032)
6.2 North America AAV Gene Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America AAV Gene Therapy Drugs Market Size by Country (2021–2026)
6.4 North America AAV Gene Therapy Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AAV Gene Therapy Drugs Market Size (2021–2032)
7.2 Europe AAV Gene Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe AAV Gene Therapy Drugs Market Size by Country (2021–2026)
7.4 Europe AAV Gene Therapy Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AAV Gene Therapy Drugs Market Size (2021–2032)
8.2 Asia-Pacific AAV Gene Therapy Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific AAV Gene Therapy Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific AAV Gene Therapy Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AAV Gene Therapy Drugs Market Size (2021–2032)
9.2 Latin America AAV Gene Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America AAV Gene Therapy Drugs Market Size by Country (2021–2026)
9.4 Latin America AAV Gene Therapy Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AAV Gene Therapy Drugs Market Size (2021–2032)
10.2 Middle East & Africa AAV Gene Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa AAV Gene Therapy Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa AAV Gene Therapy Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Avexis/Novartis (Zolgensma)
11.1.1 Avexis/Novartis (Zolgensma) Company Details
11.1.2 Avexis/Novartis (Zolgensma) Business Overview
11.1.3 Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Introduction
11.1.4 Avexis/Novartis (Zolgensma) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.1.5 Avexis/Novartis (Zolgensma) Recent Development
11.2 Sarepta Therapeutics (Elevidys)
11.2.1 Sarepta Therapeutics (Elevidys) Company Details
11.2.2 Sarepta Therapeutics (Elevidys) Business Overview
11.2.3 Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Introduction
11.2.4 Sarepta Therapeutics (Elevidys) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.2.5 Sarepta Therapeutics (Elevidys) Recent Development
11.3 Spark/Roche (Luxturna)
11.3.1 Spark/Roche (Luxturna) Company Details
11.3.2 Spark/Roche (Luxturna) Business Overview
11.3.3 Spark/Roche (Luxturna) AAV Gene Therapy Drugs Introduction
11.3.4 Spark/Roche (Luxturna) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.3.5 Spark/Roche (Luxturna) Recent Development
11.4 PTC Therapeutics (Upstaza)
11.4.1 PTC Therapeutics (Upstaza) Company Details
11.4.2 PTC Therapeutics (Upstaza) Business Overview
11.4.3 PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Introduction
11.4.4 PTC Therapeutics (Upstaza) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.4.5 PTC Therapeutics (Upstaza) Recent Development
11.5 BioMarin (Roctavian)
11.5.1 BioMarin (Roctavian) Company Details
11.5.2 BioMarin (Roctavian) Business Overview
11.5.3 BioMarin (Roctavian) AAV Gene Therapy Drugs Introduction
11.5.4 BioMarin (Roctavian) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.5.5 BioMarin (Roctavian) Recent Development
11.6 CSL/uniQure (Hemgenix&Glybera)
11.6.1 CSL/uniQure (Hemgenix&Glybera) Company Details
11.6.2 CSL/uniQure (Hemgenix&Glybera) Business Overview
11.6.3 CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Introduction
11.6.4 CSL/uniQure (Hemgenix&Glybera) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.6.5 CSL/uniQure (Hemgenix&Glybera) Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer AAV Gene Therapy Drugs Introduction
11.7.4 Pfizer Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.7.5 Pfizer Recent Development
11.8 Beijing Innovikang (Pipeline)
11.8.1 Beijing Innovikang (Pipeline) Company Details
11.8.2 Beijing Innovikang (Pipeline) Business Overview
11.8.3 Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Introduction
11.8.4 Beijing Innovikang (Pipeline) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.8.5 Beijing Innovikang (Pipeline) Recent Development
11.9 Suzhou NoJieBeig (Pipeline)
11.9.1 Suzhou NoJieBeig (Pipeline) Company Details
11.9.2 Suzhou NoJieBeig (Pipeline) Business Overview
11.9.3 Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Introduction
11.9.4 Suzhou NoJieBeig (Pipeline) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.9.5 Suzhou NoJieBeig (Pipeline) Recent Development
11.10 Belief BioMed (Pipeline)
11.10.1 Belief BioMed (Pipeline) Company Details
11.10.2 Belief BioMed (Pipeline) Business Overview
11.10.3 Belief BioMed (Pipeline) AAV Gene Therapy Drugs Introduction
11.10.4 Belief BioMed (Pipeline) Revenue in AAV Gene Therapy Drugs Business (2021–2026)
11.10.5 Belief BioMed (Pipeline) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global AAV Gene Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of scAAV9 Vector
Table 3. Key Players of AVV2 Vector
Table 4. Key Players of AVV5 Vector
Table 5. Key Players of AAVrh74 Vector
Table 6. Global AAV Gene Therapy Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global AAV Gene Therapy Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global AAV Gene Therapy Drugs Market Size by Region (US$ Million), 2021–2026
Table 9. Global AAV Gene Therapy Drugs Market Share by Region (2021–2026)
Table 10. Global AAV Gene Therapy Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global AAV Gene Therapy Drugs Market Share by Region (2027–2032)
Table 12. AAV Gene Therapy Drugs Market Trends
Table 13. AAV Gene Therapy Drugs Market Drivers
Table 14. AAV Gene Therapy Drugs Market Challenges
Table 15. AAV Gene Therapy Drugs Market Restraints
Table 16. Global AAV Gene Therapy Drugs Revenue by Players (US$ Million), 2021–2026
Table 17. Global AAV Gene Therapy Drugs Market Share by Players (2021–2026)
Table 18. Global Top AAV Gene Therapy Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on AAV Gene Therapy Drugs Revenue, 2025
Table 19. Ranking of Global Top AAV Gene Therapy Drugs Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by AAV Gene Therapy Drugs Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of AAV Gene Therapy Drugs, Headquarters and Area Served
Table 22. Global Key Players of AAV Gene Therapy Drugs, Products and Applications
Table 23. Global Key Players of AAV Gene Therapy Drugs, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global AAV Gene Therapy Drugs Market Size by Type (US$ Million), 2021–2026
Table 26. Global AAV Gene Therapy Drugs Revenue Market Share by Type (2021–2026)
Table 27. Global AAV Gene Therapy Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global AAV Gene Therapy Drugs Revenue Market Share by Type (2027–2032)
Table 29. Global AAV Gene Therapy Drugs Market Size by Application (US$ Million), 2021–2026
Table 30. Global AAV Gene Therapy Drugs Revenue Market Share by Application (2021–2026)
Table 31. Global AAV Gene Therapy Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global AAV Gene Therapy Drugs Revenue Market Share by Application (2027–2032)
Table 33. North America AAV Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 35. North America AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 36. Europe AAV Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 38. Europe AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific AAV Gene Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific AAV Gene Therapy Drugs Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific AAV Gene Therapy Drugs Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America AAV Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa AAV Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 48. Avexis/Novartis (Zolgensma) Company Details
Table 49. Avexis/Novartis (Zolgensma) Business Overview
Table 50. Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Product
Table 51. Avexis/Novartis (Zolgensma) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 52. Avexis/Novartis (Zolgensma) Recent Development
Table 53. Sarepta Therapeutics (Elevidys) Company Details
Table 54. Sarepta Therapeutics (Elevidys) Business Overview
Table 55. Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Product
Table 56. Sarepta Therapeutics (Elevidys) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 57. Sarepta Therapeutics (Elevidys) Recent Development
Table 58. Spark/Roche (Luxturna) Company Details
Table 59. Spark/Roche (Luxturna) Business Overview
Table 60. Spark/Roche (Luxturna) AAV Gene Therapy Drugs Product
Table 61. Spark/Roche (Luxturna) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 62. Spark/Roche (Luxturna) Recent Development
Table 63. PTC Therapeutics (Upstaza) Company Details
Table 64. PTC Therapeutics (Upstaza) Business Overview
Table 65. PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Product
Table 66. PTC Therapeutics (Upstaza) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 67. PTC Therapeutics (Upstaza) Recent Development
Table 68. BioMarin (Roctavian) Company Details
Table 69. BioMarin (Roctavian) Business Overview
Table 70. BioMarin (Roctavian) AAV Gene Therapy Drugs Product
Table 71. BioMarin (Roctavian) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 72. BioMarin (Roctavian) Recent Development
Table 73. CSL/uniQure (Hemgenix&Glybera) Company Details
Table 74. CSL/uniQure (Hemgenix&Glybera) Business Overview
Table 75. CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Product
Table 76. CSL/uniQure (Hemgenix&Glybera) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 77. CSL/uniQure (Hemgenix&Glybera) Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer AAV Gene Therapy Drugs Product
Table 81. Pfizer Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 82. Pfizer Recent Development
Table 83. Beijing Innovikang (Pipeline) Company Details
Table 84. Beijing Innovikang (Pipeline) Business Overview
Table 85. Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Product
Table 86. Beijing Innovikang (Pipeline) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 87. Beijing Innovikang (Pipeline) Recent Development
Table 88. Suzhou NoJieBeig (Pipeline) Company Details
Table 89. Suzhou NoJieBeig (Pipeline) Business Overview
Table 90. Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Product
Table 91. Suzhou NoJieBeig (Pipeline) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 92. Suzhou NoJieBeig (Pipeline) Recent Development
Table 93. Belief BioMed (Pipeline) Company Details
Table 94. Belief BioMed (Pipeline) Business Overview
Table 95. Belief BioMed (Pipeline) AAV Gene Therapy Drugs Product
Table 96. Belief BioMed (Pipeline) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 97. Belief BioMed (Pipeline) Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. AAV Gene Therapy Drugs Picture
Figure 2. Global AAV Gene Therapy Drugs Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global AAV Gene Therapy Drugs Market Share by Type: 2025 vs 2032
Figure 4. scAAV9 Vector Features
Figure 5. AVV2 Vector Features
Figure 6. AVV5 Vector Features
Figure 7. AAVrh74 Vector Features
Figure 8. Global AAV Gene Therapy Drugs Market Size by Application (US$ Million), 2021–2032
Figure 9. Global AAV Gene Therapy Drugs Market Share by Application: 2025 vs 2032
Figure 10. Spinal Muscular Atrophy (SMA) Case Studies
Figure 11. Ophthalmic Diseases Case Studies
Figure 12. Hemophilia Case Studies
Figure 13. Duchenne Muscular Dystrophy (DMD) Case Studies
Figure 14. Others Case Studies
Figure 15. AAV Gene Therapy Drugs Report Years Considered
Figure 16. Global AAV Gene Therapy Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 17. Global AAV Gene Therapy Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global AAV Gene Therapy Drugs Market Share by Region: 2025 vs 2032
Figure 19. Global AAV Gene Therapy Drugs Market Share by Players in 2025
Figure 20. Global AAV Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by AAV Gene Therapy Drugs Revenue in 2025
Figure 22. North America AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. North America AAV Gene Therapy Drugs Market Share by Country (2021–2032)
Figure 24. United States AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Canada AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe AAV Gene Therapy Drugs Market Share by Country (2021–2032)
Figure 28. Germany AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. France AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. U.K. AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Italy AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Russia AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Ireland AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific AAV Gene Therapy Drugs Market Share by Region (2021–2032)
Figure 36. China AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Japan AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. South Korea AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Southeast Asia AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. India AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Australia & New Zealand AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America AAV Gene Therapy Drugs Market Share by Country (2021–2032)
Figure 44. Mexico AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Brazil AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa AAV Gene Therapy Drugs Market Share by Country (2021–2032)
Figure 48. Israel AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Saudi Arabia AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. UAE AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Avexis/Novartis (Zolgensma) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 52. Sarepta Therapeutics (Elevidys) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 53. Spark/Roche (Luxturna) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 54. PTC Therapeutics (Upstaza) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 55. BioMarin (Roctavian) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 56. CSL/uniQure (Hemgenix&Glybera) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 57. Pfizer Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 58. Beijing Innovikang (Pipeline) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 59. Suzhou NoJieBeig (Pipeline) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 60. Belief BioMed (Pipeline) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global AAV Gene Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of scAAV9 Vector
Table 3. Key Players of AVV2 Vector
Table 4. Key Players of AVV5 Vector
Table 5. Key Players of AAVrh74 Vector
Table 6. Global AAV Gene Therapy Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global AAV Gene Therapy Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global AAV Gene Therapy Drugs Market Size by Region (US$ Million), 2021–2026
Table 9. Global AAV Gene Therapy Drugs Market Share by Region (2021–2026)
Table 10. Global AAV Gene Therapy Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global AAV Gene Therapy Drugs Market Share by Region (2027–2032)
Table 12. AAV Gene Therapy Drugs Market Trends
Table 13. AAV Gene Therapy Drugs Market Drivers
Table 14. AAV Gene Therapy Drugs Market Challenges
Table 15. AAV Gene Therapy Drugs Market Restraints
Table 16. Global AAV Gene Therapy Drugs Revenue by Players (US$ Million), 2021–2026
Table 17. Global AAV Gene Therapy Drugs Market Share by Players (2021–2026)
Table 18. Global Top AAV Gene Therapy Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on AAV Gene Therapy Drugs Revenue, 2025
Table 19. Ranking of Global Top AAV Gene Therapy Drugs Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by AAV Gene Therapy Drugs Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of AAV Gene Therapy Drugs, Headquarters and Area Served
Table 22. Global Key Players of AAV Gene Therapy Drugs, Products and Applications
Table 23. Global Key Players of AAV Gene Therapy Drugs, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global AAV Gene Therapy Drugs Market Size by Type (US$ Million), 2021–2026
Table 26. Global AAV Gene Therapy Drugs Revenue Market Share by Type (2021–2026)
Table 27. Global AAV Gene Therapy Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global AAV Gene Therapy Drugs Revenue Market Share by Type (2027–2032)
Table 29. Global AAV Gene Therapy Drugs Market Size by Application (US$ Million), 2021–2026
Table 30. Global AAV Gene Therapy Drugs Revenue Market Share by Application (2021–2026)
Table 31. Global AAV Gene Therapy Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global AAV Gene Therapy Drugs Revenue Market Share by Application (2027–2032)
Table 33. North America AAV Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 35. North America AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 36. Europe AAV Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 38. Europe AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific AAV Gene Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific AAV Gene Therapy Drugs Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific AAV Gene Therapy Drugs Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America AAV Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa AAV Gene Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa AAV Gene Therapy Drugs Market Size by Country (US$ Million), 2027–2032
Table 48. Avexis/Novartis (Zolgensma) Company Details
Table 49. Avexis/Novartis (Zolgensma) Business Overview
Table 50. Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Product
Table 51. Avexis/Novartis (Zolgensma) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 52. Avexis/Novartis (Zolgensma) Recent Development
Table 53. Sarepta Therapeutics (Elevidys) Company Details
Table 54. Sarepta Therapeutics (Elevidys) Business Overview
Table 55. Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Product
Table 56. Sarepta Therapeutics (Elevidys) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 57. Sarepta Therapeutics (Elevidys) Recent Development
Table 58. Spark/Roche (Luxturna) Company Details
Table 59. Spark/Roche (Luxturna) Business Overview
Table 60. Spark/Roche (Luxturna) AAV Gene Therapy Drugs Product
Table 61. Spark/Roche (Luxturna) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 62. Spark/Roche (Luxturna) Recent Development
Table 63. PTC Therapeutics (Upstaza) Company Details
Table 64. PTC Therapeutics (Upstaza) Business Overview
Table 65. PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Product
Table 66. PTC Therapeutics (Upstaza) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 67. PTC Therapeutics (Upstaza) Recent Development
Table 68. BioMarin (Roctavian) Company Details
Table 69. BioMarin (Roctavian) Business Overview
Table 70. BioMarin (Roctavian) AAV Gene Therapy Drugs Product
Table 71. BioMarin (Roctavian) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 72. BioMarin (Roctavian) Recent Development
Table 73. CSL/uniQure (Hemgenix&Glybera) Company Details
Table 74. CSL/uniQure (Hemgenix&Glybera) Business Overview
Table 75. CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Product
Table 76. CSL/uniQure (Hemgenix&Glybera) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 77. CSL/uniQure (Hemgenix&Glybera) Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer AAV Gene Therapy Drugs Product
Table 81. Pfizer Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 82. Pfizer Recent Development
Table 83. Beijing Innovikang (Pipeline) Company Details
Table 84. Beijing Innovikang (Pipeline) Business Overview
Table 85. Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Product
Table 86. Beijing Innovikang (Pipeline) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 87. Beijing Innovikang (Pipeline) Recent Development
Table 88. Suzhou NoJieBeig (Pipeline) Company Details
Table 89. Suzhou NoJieBeig (Pipeline) Business Overview
Table 90. Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Product
Table 91. Suzhou NoJieBeig (Pipeline) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 92. Suzhou NoJieBeig (Pipeline) Recent Development
Table 93. Belief BioMed (Pipeline) Company Details
Table 94. Belief BioMed (Pipeline) Business Overview
Table 95. Belief BioMed (Pipeline) AAV Gene Therapy Drugs Product
Table 96. Belief BioMed (Pipeline) Revenue in AAV Gene Therapy Drugs Business (US$ Million), 2021–2026
Table 97. Belief BioMed (Pipeline) Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. AAV Gene Therapy Drugs Picture
Figure 2. Global AAV Gene Therapy Drugs Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global AAV Gene Therapy Drugs Market Share by Type: 2025 vs 2032
Figure 4. scAAV9 Vector Features
Figure 5. AVV2 Vector Features
Figure 6. AVV5 Vector Features
Figure 7. AAVrh74 Vector Features
Figure 8. Global AAV Gene Therapy Drugs Market Size by Application (US$ Million), 2021–2032
Figure 9. Global AAV Gene Therapy Drugs Market Share by Application: 2025 vs 2032
Figure 10. Spinal Muscular Atrophy (SMA) Case Studies
Figure 11. Ophthalmic Diseases Case Studies
Figure 12. Hemophilia Case Studies
Figure 13. Duchenne Muscular Dystrophy (DMD) Case Studies
Figure 14. Others Case Studies
Figure 15. AAV Gene Therapy Drugs Report Years Considered
Figure 16. Global AAV Gene Therapy Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 17. Global AAV Gene Therapy Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global AAV Gene Therapy Drugs Market Share by Region: 2025 vs 2032
Figure 19. Global AAV Gene Therapy Drugs Market Share by Players in 2025
Figure 20. Global AAV Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by AAV Gene Therapy Drugs Revenue in 2025
Figure 22. North America AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. North America AAV Gene Therapy Drugs Market Share by Country (2021–2032)
Figure 24. United States AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Canada AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe AAV Gene Therapy Drugs Market Share by Country (2021–2032)
Figure 28. Germany AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. France AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. U.K. AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Italy AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Russia AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Ireland AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific AAV Gene Therapy Drugs Market Share by Region (2021–2032)
Figure 36. China AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Japan AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. South Korea AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Southeast Asia AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. India AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Australia & New Zealand AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America AAV Gene Therapy Drugs Market Share by Country (2021–2032)
Figure 44. Mexico AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Brazil AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa AAV Gene Therapy Drugs Market Share by Country (2021–2032)
Figure 48. Israel AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Saudi Arabia AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. UAE AAV Gene Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Avexis/Novartis (Zolgensma) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 52. Sarepta Therapeutics (Elevidys) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 53. Spark/Roche (Luxturna) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 54. PTC Therapeutics (Upstaza) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 55. BioMarin (Roctavian) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 56. CSL/uniQure (Hemgenix&Glybera) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 57. Pfizer Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 58. Beijing Innovikang (Pipeline) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 59. Suzhou NoJieBeig (Pipeline) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 60. Belief BioMed (Pipeline) Revenue Growth Rate in AAV Gene Therapy Drugs Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232